Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Menopause | 38 | 2024 | 1661 | 4.100 |
Why?
|
Sexual Dysfunction, Physiological | 14 | 2024 | 363 | 2.990 |
Why?
|
Sexual Dysfunctions, Psychological | 16 | 2022 | 193 | 2.530 |
Why?
|
Postmenopause | 20 | 2020 | 2516 | 2.040 |
Why?
|
Sexuality | 6 | 2023 | 180 | 1.840 |
Why?
|
Estrogen Replacement Therapy | 18 | 2023 | 1206 | 1.790 |
Why?
|
Estrogens | 17 | 2023 | 1529 | 1.520 |
Why?
|
Testosterone | 17 | 2025 | 2495 | 1.470 |
Why?
|
Hot Flashes | 14 | 2024 | 330 | 1.410 |
Why?
|
Sexual Behavior | 15 | 2023 | 2192 | 1.240 |
Why?
|
Androgens | 10 | 2017 | 1278 | 1.160 |
Why?
|
Libido | 9 | 2015 | 123 | 1.070 |
Why?
|
Hormone Replacement Therapy | 12 | 2023 | 752 | 1.040 |
Why?
|
Estradiol | 15 | 2019 | 1947 | 1.000 |
Why?
|
Menopause, Premature | 4 | 2022 | 124 | 1.000 |
Why?
|
Ovariectomy | 6 | 2007 | 613 | 0.910 |
Why?
|
Vaginal Diseases | 3 | 2021 | 103 | 0.850 |
Why?
|
Estrogens, Conjugated (USP) | 5 | 2018 | 274 | 0.840 |
Why?
|
Women's Health | 7 | 2018 | 2083 | 0.530 |
Why?
|
Vulva | 3 | 2019 | 84 | 0.460 |
Why?
|
Administration, Cutaneous | 10 | 2008 | 715 | 0.430 |
Why?
|
Atrophy | 6 | 2020 | 1629 | 0.380 |
Why?
|
Anti-Mullerian Hormone | 2 | 2025 | 420 | 0.380 |
Why?
|
Perimenopause | 6 | 2018 | 142 | 0.380 |
Why?
|
Endothelial Growth Factors | 5 | 2000 | 680 | 0.370 |
Why?
|
Lymphokines | 5 | 2000 | 911 | 0.360 |
Why?
|
Endocrine Glands | 2 | 2010 | 101 | 0.350 |
Why?
|
Dyspareunia | 3 | 2019 | 48 | 0.340 |
Why?
|
Cyclohexanols | 3 | 2015 | 126 | 0.340 |
Why?
|
Vagina | 7 | 2020 | 848 | 0.340 |
Why?
|
Female | 100 | 2025 | 396159 | 0.320 |
Why?
|
Endometrium | 8 | 2004 | 405 | 0.320 |
Why?
|
Administration, Intravaginal | 6 | 2019 | 149 | 0.310 |
Why?
|
Menstrual Cycle | 6 | 2022 | 540 | 0.280 |
Why?
|
Polycystic Ovary Syndrome | 3 | 2025 | 391 | 0.280 |
Why?
|
Climacteric | 2 | 2003 | 57 | 0.270 |
Why?
|
Psychometrics | 1 | 2016 | 3060 | 0.270 |
Why?
|
Societies, Medical | 3 | 2015 | 3954 | 0.260 |
Why?
|
Vaginal Smears | 1 | 2008 | 506 | 0.250 |
Why?
|
Endometrial Neoplasms | 4 | 2022 | 1379 | 0.230 |
Why?
|
Humans | 102 | 2025 | 766011 | 0.230 |
Why?
|
Middle Aged | 48 | 2024 | 223058 | 0.220 |
Why?
|
Ovary | 4 | 2005 | 957 | 0.210 |
Why?
|
Progesterone | 1 | 2007 | 752 | 0.210 |
Why?
|
HIV Wasting Syndrome | 1 | 2003 | 99 | 0.210 |
Why?
|
Depressive Disorder | 4 | 2018 | 3713 | 0.210 |
Why?
|
Physical Examination | 1 | 2008 | 1265 | 0.200 |
Why?
|
Personal Satisfaction | 3 | 2012 | 641 | 0.200 |
Why?
|
Patient Acceptance of Health Care | 4 | 2012 | 3230 | 0.200 |
Why?
|
Vasomotor System | 3 | 2024 | 207 | 0.200 |
Why?
|
Quality of Life | 12 | 2024 | 13470 | 0.190 |
Why?
|
Dehydroepiandrosterone | 2 | 2018 | 248 | 0.190 |
Why?
|
Mood Disorders | 1 | 2008 | 1126 | 0.190 |
Why?
|
Thromboembolism | 1 | 2008 | 1003 | 0.190 |
Why?
|
Aromatase Inhibitors | 1 | 2006 | 518 | 0.190 |
Why?
|
Hysterectomy | 4 | 2005 | 865 | 0.180 |
Why?
|
Administration, Oral | 5 | 2018 | 4015 | 0.170 |
Why?
|
Gonadal Steroid Hormones | 3 | 2018 | 704 | 0.170 |
Why?
|
Vaginal Creams, Foams, and Jellies | 1 | 2019 | 62 | 0.160 |
Why?
|
Embryonic and Fetal Development | 3 | 1998 | 419 | 0.160 |
Why?
|
Neovascularization, Physiologic | 4 | 2004 | 1377 | 0.160 |
Why?
|
Preoperative Care | 1 | 2008 | 2277 | 0.160 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2335 | 0.160 |
Why?
|
Patient Selection | 2 | 2008 | 4257 | 0.150 |
Why?
|
Lubricants | 1 | 2018 | 26 | 0.150 |
Why?
|
Methyltestosterone | 3 | 2004 | 19 | 0.150 |
Why?
|
Affect | 2 | 2003 | 1498 | 0.150 |
Why?
|
Sweating | 1 | 2019 | 155 | 0.150 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2018 | 134 | 0.150 |
Why?
|
Adrenal Cortex | 1 | 1998 | 134 | 0.140 |
Why?
|
Adult | 45 | 2025 | 223109 | 0.140 |
Why?
|
Infertility | 2 | 2023 | 656 | 0.140 |
Why?
|
Cross-Over Studies | 5 | 2008 | 2108 | 0.140 |
Why?
|
Medroxyprogesterone Acetate | 2 | 2000 | 153 | 0.140 |
Why?
|
Breast Neoplasms | 4 | 2019 | 21062 | 0.130 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2022 | 532 | 0.130 |
Why?
|
Adrenocorticotropic Hormone | 1 | 1998 | 618 | 0.130 |
Why?
|
C-Reactive Protein | 1 | 2008 | 3849 | 0.130 |
Why?
|
Citalopram | 2 | 2012 | 402 | 0.120 |
Why?
|
Translating | 1 | 2016 | 144 | 0.120 |
Why?
|
Infertility, Female | 2 | 2014 | 763 | 0.120 |
Why?
|
Mind-Body Relations, Metaphysical | 1 | 2014 | 34 | 0.120 |
Why?
|
Double-Blind Method | 12 | 2019 | 12433 | 0.120 |
Why?
|
Physical Therapy Modalities | 1 | 2018 | 533 | 0.120 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2015 | 147 | 0.110 |
Why?
|
Endometriosis | 3 | 1998 | 870 | 0.110 |
Why?
|
Endothelium, Vascular | 2 | 1998 | 4423 | 0.110 |
Why?
|
North America | 2 | 2014 | 1285 | 0.110 |
Why?
|
Attitude | 1 | 2019 | 769 | 0.110 |
Why?
|
Tamoxifen | 1 | 2018 | 964 | 0.110 |
Why?
|
Product Labeling | 1 | 2014 | 75 | 0.110 |
Why?
|
Practice Guidelines as Topic | 2 | 2008 | 7426 | 0.110 |
Why?
|
Receptor, IGF Type 2 | 1 | 1993 | 35 | 0.110 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2008 | 558 | 0.110 |
Why?
|
Vascular Endothelial Growth Factors | 5 | 2000 | 754 | 0.110 |
Why?
|
Self Report | 3 | 2022 | 3774 | 0.100 |
Why?
|
Diabetes, Gestational | 1 | 2022 | 1263 | 0.100 |
Why?
|
Laser Therapy | 1 | 2018 | 1109 | 0.090 |
Why?
|
Research | 2 | 2018 | 1974 | 0.090 |
Why?
|
Psychotherapy, Group | 1 | 2014 | 417 | 0.090 |
Why?
|
Fertilization in Vitro | 4 | 2001 | 1308 | 0.090 |
Why?
|
Receptor, IGF Type 1 | 1 | 1993 | 385 | 0.090 |
Why?
|
Health Surveys | 3 | 2009 | 4057 | 0.090 |
Why?
|
Parity | 2 | 2025 | 932 | 0.090 |
Why?
|
Anxiety | 2 | 2022 | 4674 | 0.090 |
Why?
|
Estrogen Antagonists | 2 | 2003 | 150 | 0.090 |
Why?
|
Premenopause | 2 | 2004 | 1038 | 0.080 |
Why?
|
Muscles | 1 | 1994 | 1578 | 0.080 |
Why?
|
Consensus | 4 | 2024 | 3200 | 0.080 |
Why?
|
Receptor, Insulin | 1 | 1993 | 837 | 0.080 |
Why?
|
Uterus | 1 | 1993 | 661 | 0.080 |
Why?
|
Nurses | 1 | 2018 | 2505 | 0.080 |
Why?
|
Pregnancy | 12 | 2024 | 30253 | 0.080 |
Why?
|
Treatment Outcome | 15 | 2021 | 65236 | 0.080 |
Why?
|
Stress, Psychological | 3 | 2014 | 4528 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 10389 | 0.070 |
Why?
|
Aged | 15 | 2019 | 171233 | 0.070 |
Why?
|
Orgasm | 3 | 2014 | 63 | 0.070 |
Why?
|
Information Services | 1 | 2009 | 240 | 0.070 |
Why?
|
Mental Disorders | 1 | 2007 | 6873 | 0.070 |
Why?
|
Prevalence | 6 | 2025 | 15833 | 0.070 |
Why?
|
Transferrin | 1 | 2008 | 283 | 0.070 |
Why?
|
Fetus | 1 | 1994 | 1878 | 0.070 |
Why?
|
Risk Factors | 9 | 2022 | 74870 | 0.070 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2010 | 399 | 0.070 |
Why?
|
Hydrocortisone | 1 | 2014 | 1832 | 0.070 |
Why?
|
Expert Testimony | 1 | 2008 | 266 | 0.070 |
Why?
|
Prospective Studies | 9 | 2024 | 54818 | 0.070 |
Why?
|
United States | 12 | 2018 | 72914 | 0.060 |
Why?
|
Age Distribution | 2 | 2009 | 2865 | 0.060 |
Why?
|
Prealbumin | 1 | 2008 | 266 | 0.060 |
Why?
|
Migraine Disorders | 1 | 2018 | 1731 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 6 | 2004 | 3504 | 0.060 |
Why?
|
Follicle Stimulating Hormone | 4 | 2001 | 731 | 0.060 |
Why?
|
Gene Expression | 2 | 1997 | 7583 | 0.060 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2008 | 694 | 0.060 |
Why?
|
Health Services | 1 | 2010 | 756 | 0.060 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2015 | 1102 | 0.060 |
Why?
|
Age Factors | 5 | 2024 | 18384 | 0.060 |
Why?
|
Hyperandrogenism | 1 | 2025 | 46 | 0.060 |
Why?
|
Uterine Hemorrhage | 2 | 2004 | 235 | 0.060 |
Why?
|
Sex Counseling | 1 | 2004 | 18 | 0.060 |
Why?
|
Levonorgestrel | 1 | 2004 | 76 | 0.060 |
Why?
|
Body Mass Index | 4 | 2025 | 13044 | 0.060 |
Why?
|
Acupuncture Therapy | 1 | 2008 | 466 | 0.060 |
Why?
|
Embryo Transfer | 2 | 1999 | 526 | 0.060 |
Why?
|
Evidence-Based Medicine | 2 | 2014 | 3687 | 0.060 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2008 | 1132 | 0.060 |
Why?
|
Thyroxine | 1 | 2007 | 665 | 0.060 |
Why?
|
Female Urogenital Diseases | 1 | 2024 | 57 | 0.050 |
Why?
|
Ointments | 1 | 2003 | 58 | 0.050 |
Why?
|
Cross-Sectional Studies | 5 | 2018 | 26283 | 0.050 |
Why?
|
Drug Implants | 1 | 2004 | 230 | 0.050 |
Why?
|
Contraceptive Agents, Female | 1 | 2004 | 123 | 0.050 |
Why?
|
Coronary Disease | 1 | 2018 | 5923 | 0.050 |
Why?
|
Risk Assessment | 2 | 2019 | 24299 | 0.050 |
Why?
|
Arousal | 2 | 2012 | 1175 | 0.050 |
Why?
|
Gynecology | 1 | 2009 | 535 | 0.050 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2004 | 272 | 0.050 |
Why?
|
Semen | 1 | 2006 | 354 | 0.050 |
Why?
|
Diabetes Complications | 1 | 2010 | 1318 | 0.050 |
Why?
|
Gels | 1 | 2004 | 419 | 0.050 |
Why?
|
HIV Infections | 3 | 2018 | 17531 | 0.050 |
Why?
|
Injections, Intramuscular | 1 | 2004 | 553 | 0.050 |
Why?
|
Infertility, Male | 1 | 2006 | 395 | 0.050 |
Why?
|
Health Promotion | 1 | 2014 | 2208 | 0.050 |
Why?
|
Hyperinsulinism | 1 | 2005 | 402 | 0.050 |
Why?
|
Women | 1 | 2004 | 226 | 0.050 |
Why?
|
Heart Arrest | 1 | 1992 | 1517 | 0.050 |
Why?
|
Endocrine System Diseases | 1 | 2004 | 243 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15647 | 0.050 |
Why?
|
Spermatozoa | 1 | 2006 | 629 | 0.050 |
Why?
|
Ovarian Hyperstimulation Syndrome | 2 | 1999 | 46 | 0.050 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14751 | 0.050 |
Why?
|
Depression | 4 | 2022 | 8237 | 0.050 |
Why?
|
Hormones | 2 | 2020 | 864 | 0.050 |
Why?
|
Testosterone Congeners | 1 | 2001 | 62 | 0.040 |
Why?
|
Nitriles | 1 | 2006 | 981 | 0.040 |
Why?
|
Personality Inventory | 1 | 2003 | 1018 | 0.040 |
Why?
|
Laparoscopy | 1 | 1992 | 2038 | 0.040 |
Why?
|
Triazoles | 1 | 2006 | 897 | 0.040 |
Why?
|
Amenorrhea | 1 | 2023 | 470 | 0.040 |
Why?
|
Ovarian Follicle | 1 | 2001 | 243 | 0.040 |
Why?
|
Antidepressive Agents | 3 | 2009 | 2903 | 0.040 |
Why?
|
Primary Health Care | 3 | 2012 | 4736 | 0.040 |
Why?
|
Patient Satisfaction | 3 | 2024 | 3479 | 0.040 |
Why?
|
Adiponectin | 1 | 2025 | 1120 | 0.040 |
Why?
|
Sleep | 1 | 2015 | 4823 | 0.040 |
Why?
|
Drug Interactions | 1 | 2003 | 1416 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2003 | 6015 | 0.040 |
Why?
|
Progestins | 1 | 2000 | 300 | 0.040 |
Why?
|
Ovarian Cysts | 1 | 1999 | 107 | 0.040 |
Why?
|
Pregnancy Rate | 2 | 1999 | 656 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2008 | 3229 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11506 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2004 | 8040 | 0.040 |
Why?
|
Estrogens, Non-Steroidal | 1 | 1997 | 49 | 0.040 |
Why?
|
Diethylstilbestrol | 1 | 1997 | 84 | 0.040 |
Why?
|
Adolescent | 5 | 2022 | 88804 | 0.030 |
Why?
|
Ovulation | 1 | 1998 | 178 | 0.030 |
Why?
|
Aging | 4 | 2020 | 8731 | 0.030 |
Why?
|
Surgical Procedures, Operative | 1 | 2008 | 1945 | 0.030 |
Why?
|
Cells, Cultured | 5 | 2000 | 18972 | 0.030 |
Why?
|
Health Status | 4 | 2012 | 4083 | 0.030 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2008 | 2041 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 1993 | 11888 | 0.030 |
Why?
|
Massachusetts | 2 | 2025 | 8878 | 0.030 |
Why?
|
Genitalia, Female | 1 | 1995 | 146 | 0.030 |
Why?
|
Macrophage Activation | 1 | 1997 | 552 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2007 | 4912 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 14061 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2003 | 6307 | 0.030 |
Why?
|
von Willebrand Factor | 1 | 1998 | 676 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2015 | 10731 | 0.030 |
Why?
|
Adipose Tissue | 1 | 2005 | 3314 | 0.030 |
Why?
|
RNA, Messenger | 4 | 2000 | 12768 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14645 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2009 | 15887 | 0.030 |
Why?
|
Restriction Mapping | 1 | 1993 | 848 | 0.030 |
Why?
|
Lubrication | 1 | 2012 | 22 | 0.020 |
Why?
|
Young Adult | 2 | 2009 | 59870 | 0.020 |
Why?
|
Pregnancy Outcome | 2 | 2001 | 2969 | 0.020 |
Why?
|
Patient Preference | 1 | 2019 | 952 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1993 | 705 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2008 | 4904 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3341 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2009 | 4813 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 1994 | 1697 | 0.020 |
Why?
|
Cohort Studies | 3 | 2025 | 41652 | 0.020 |
Why?
|
Obesity | 2 | 2025 | 13078 | 0.020 |
Why?
|
Pilot Projects | 3 | 2014 | 8733 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 1997 | 1409 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 1407 | 0.020 |
Why?
|
Attention | 1 | 2001 | 2415 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9654 | 0.020 |
Why?
|
Tissue Distribution | 1 | 1994 | 2268 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2015 | 59526 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2018 | 1899 | 0.020 |
Why?
|
Epithelium | 1 | 1994 | 1601 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1998 | 2241 | 0.020 |
Why?
|
Piperidines | 1 | 1998 | 1662 | 0.020 |
Why?
|
Placenta Diseases | 1 | 1991 | 199 | 0.020 |
Why?
|
Marital Status | 1 | 2010 | 426 | 0.020 |
Why?
|
Immune System | 1 | 1994 | 799 | 0.020 |
Why?
|
Psychology | 1 | 2010 | 354 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2012 | 811 | 0.020 |
Why?
|
History, 21st Century | 1 | 2014 | 1573 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2513 | 0.020 |
Why?
|
Cytokines | 2 | 2000 | 7425 | 0.020 |
Why?
|
Patient Compliance | 1 | 2018 | 2694 | 0.020 |
Why?
|
Mammaplasty | 1 | 1998 | 1264 | 0.020 |
Why?
|
Placenta Accreta | 1 | 1991 | 242 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2008 | 15803 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 1997 | 2630 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2015 | 1672 | 0.020 |
Why?
|
Income | 1 | 2015 | 1874 | 0.020 |
Why?
|
History, 20th Century | 1 | 2014 | 2761 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9600 | 0.020 |
Why?
|
Comorbidity | 2 | 2012 | 10572 | 0.020 |
Why?
|
Mental Health | 1 | 2000 | 3271 | 0.020 |
Why?
|
Embryo Implantation | 2 | 1998 | 271 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1987 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 1997 | 2532 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 1997 | 4521 | 0.010 |
Why?
|
Registries | 2 | 2012 | 8321 | 0.010 |
Why?
|
Placebo Effect | 1 | 2008 | 514 | 0.010 |
Why?
|
Sperm Motility | 1 | 2006 | 265 | 0.010 |
Why?
|
Lipodystrophy | 1 | 2005 | 145 | 0.010 |
Why?
|
Gestational Age | 1 | 1993 | 3615 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2014 | 2660 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1993 | 6062 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9355 | 0.010 |
Why?
|
Menstruation | 1 | 2005 | 309 | 0.010 |
Why?
|
Stromal Cells | 2 | 2000 | 1332 | 0.010 |
Why?
|
Ohio | 1 | 2004 | 320 | 0.010 |
Why?
|
Pessaries | 1 | 2003 | 15 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2010 | 12060 | 0.010 |
Why?
|
Regression Analysis | 2 | 2005 | 6321 | 0.010 |
Why?
|
Social Class | 1 | 2012 | 2009 | 0.010 |
Why?
|
Macrophages | 1 | 1997 | 5771 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2012 | 12969 | 0.010 |
Why?
|
Thorax | 1 | 2005 | 553 | 0.010 |
Why?
|
Base Sequence | 1 | 1993 | 12402 | 0.010 |
Why?
|
Retrospective Studies | 5 | 2022 | 81522 | 0.010 |
Why?
|
Self-Assessment | 1 | 2004 | 400 | 0.010 |
Why?
|
Esterification | 1 | 2001 | 37 | 0.010 |
Why?
|
Apoptosis | 1 | 1997 | 9511 | 0.010 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2002 | 238 | 0.010 |
Why?
|
Decision Making | 1 | 2015 | 3965 | 0.010 |
Why?
|
Reproduction | 1 | 2005 | 641 | 0.010 |
Why?
|
Anthropometry | 1 | 2005 | 1339 | 0.010 |
Why?
|
Animals | 2 | 2018 | 168721 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1993 | 17595 | 0.010 |
Why?
|
Ultrasonography | 2 | 2005 | 5997 | 0.010 |
Why?
|
DNA | 1 | 1993 | 7194 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 21507 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2004 | 11036 | 0.010 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2000 | 187 | 0.010 |
Why?
|
Health Priorities | 1 | 2002 | 382 | 0.010 |
Why?
|
Ovulation Induction | 1 | 2001 | 277 | 0.010 |
Why?
|
Receptors, LHRH | 1 | 1999 | 158 | 0.010 |
Why?
|
Menotropins | 1 | 1998 | 41 | 0.010 |
Why?
|
International Cooperation | 1 | 2004 | 1432 | 0.010 |
Why?
|
Receptors, Growth Factor | 1 | 1998 | 324 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2000 | 1242 | 0.010 |
Why?
|
Lipectomy | 1 | 1998 | 114 | 0.010 |
Why?
|
Male | 5 | 2006 | 363808 | 0.010 |
Why?
|
bcl-2-Associated X Protein | 1 | 1997 | 283 | 0.010 |
Why?
|
Research Design | 1 | 2012 | 6207 | 0.010 |
Why?
|
Body Composition | 1 | 2005 | 2441 | 0.010 |
Why?
|
Prolactin | 1 | 1998 | 625 | 0.010 |
Why?
|
bcl-X Protein | 1 | 1997 | 414 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1997 | 1546 | 0.010 |
Why?
|
Chorionic Gonadotropin | 1 | 1998 | 457 | 0.010 |
Why?
|
Luteinizing Hormone | 1 | 1998 | 826 | 0.010 |
Why?
|
Logistic Models | 2 | 2001 | 13271 | 0.010 |
Why?
|
Cell Polarity | 1 | 1998 | 636 | 0.010 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 1998 | 658 | 0.010 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2000 | 1133 | 0.010 |
Why?
|
Child | 1 | 2022 | 80510 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2001 | 4850 | 0.010 |
Why?
|
Random Allocation | 1 | 1998 | 2394 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39226 | 0.010 |
Why?
|
Suture Techniques | 1 | 1998 | 774 | 0.010 |
Why?
|
Oocytes | 1 | 1998 | 1170 | 0.010 |
Why?
|
Bone Density | 1 | 2005 | 3490 | 0.010 |
Why?
|
Motor Activity | 1 | 2001 | 2704 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 1998 | 1622 | 0.010 |
Why?
|
Blotting, Western | 1 | 1997 | 5019 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2005 | 4558 | 0.010 |
Why?
|
Biopsy | 1 | 2000 | 6766 | 0.000 |
Why?
|
Neuropsychological Tests | 1 | 2001 | 7121 | 0.000 |
Why?
|
Cognition | 1 | 2004 | 7048 | 0.000 |
Why?
|
Placenta | 1 | 1995 | 1728 | 0.000 |
Why?
|
Epithelial Cells | 1 | 1998 | 3682 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2001 | 15403 | 0.000 |
Why?
|
Cesarean Section | 1 | 1991 | 1431 | 0.000 |
Why?
|
Time Factors | 1 | 2001 | 40117 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1991 | 26341 | 0.000 |
Why?
|